Filling Small Batches
Advances in automation and cleanroom technology improve efficiency for small commercial quantities of aseptically filled drug products.
With the increase in drug products targeted to specific patient groups, including orphan drugs and even individualized medicine, manufacturers must consider how to optimize the manufacturing process for aseptic fill/finish of drugs in small batch sizes. Pharmaceutical Technology spoke with Joerg Zimmermann, vice-president of Development Service and External Affairs at Vetter, about these challenges and the equipment and facility options to consider.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the Author
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 14–17
Citation
When referring to this article, please cite it as J. Markarian, “Filling Small Batches" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
